Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$2.36 - $3.2 $184,733 - $250,486
-78,277 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$2.19 - $2.96 $21,996 - $29,730
10,044 Added 14.72%
78,277 $207,000
Q3 2020

Nov 17, 2020

BUY
$1.62 - $4.24 $23,805 - $62,306
14,695 Added 27.45%
68,233 $183,000
Q1 2020

May 13, 2020

BUY
$1.11 - $2.43 $20,032 - $43,854
18,047 Added 50.85%
53,538 $81,000
Q2 2019

Aug 14, 2019

BUY
$2.75 - $5.0 $97,600 - $177,455
35,491 New
35,491 $108,000

Others Institutions Holding CKPT

About Checkpoint Therapeutics, Inc.


  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $304M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.